Request Demo
Last update 28 May 2025
PACE CART19
Last update 28 May 2025
Overview
Basic Info
Drug Type Universal CAR-T |
Synonyms- |
Target |
Action modulators, inhibitors |
Mechanism B2M modulators(Beta-2-microglobulin modulators), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with PACE CART19NCT05037669
Phase I Trial of Programmed Allogeneic CRISPR-edited T Cells (PACE) Gene Edited to Eliminate Endogenous TCR, HLA-class I and HLA-class II and Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma
100 Clinical Results associated with PACE CART19
Login to view more data
100 Translational Medicine associated with PACE CART19
Login to view more data
100 Patents (Medical) associated with PACE CART19
Login to view more data
100 Deals associated with PACE CART19
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia | Phase 1 | - | 01 Jul 2022 | |
| ALK positive large B-cell lymphoma | Phase 1 | - | 01 Jul 2022 | |
| Chronic Lymphocytic Leukemia | Phase 1 | - | 01 Jul 2022 | |
| Cutaneous T-Cell Lymphoma | Phase 1 | - | 01 Jul 2022 | |
| Follicular Lymphoma | Phase 1 | - | 01 Jul 2022 | |
| High grade B-cell lymphoma | Phase 1 | - | 01 Jul 2022 | |
| Mantle-Cell Lymphoma | Phase 1 | - | 01 Jul 2022 | |
| Mediastinal large B-cell lymphoma | Phase 1 | - | 01 Jul 2022 | |
| Refractory Mature B-Cell Non-Hodgkin Lymphoma | Phase 1 | - | 01 Jul 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free